Biotech
Sunbird Bio
Sunbird Bio raises $85M Series B at $450M valuation
$85M
Total Raised
Series B
Latest Round
2018
Founded
120+
Employees
Emeryville, CA
1 min read
Quick Facts
Valuation
$450M
Latest Round Size
$85M
Latest Round Date
October 2024
Sunbird Bio: Series B Funding Round
Sunbird Bio has successfully raised $85M in Series B funding, reaching a valuation of $450M.
Company Overview
Molecular diagnostics technology
Funding Details
The Series B round was led by Deerfield Management, with participation from Casdin Capital.
Company Information
- Headquarters: Emeryville, CA
- Founded: 2018
- Employees: 120+
- Category: Biotech
Investment
Sunbird Bio plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Deerfield Management: Verified investor in Series B
- Casdin Capital: Verified investor in Series B
Key Investors
Deerfield Management
Lead Investor
Verified investor in Series B
Casdin Capital
Investor
Verified investor in Series B
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Torl Biotherapeutics
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
Editorial Team
Oct 10, 2025
1 min read•$96M
Biotech
Nilo Therapeutics
Nilo Therapeutics raises $101M Series A at $450M valuation
Nilo Therapeutics raises $101M in Series A at $450M valuation. Developing therapies based on neuro-immunology research...
Editorial Team
Oct 9, 2025
1 min read•$101M
Biotech
Arthrosi Therapeutics
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Editorial Team
Oct 8, 2025
1 min read•$153M